2FDA. Guidance for Industry--Container Closure Systems for Packaging Human Drugs and Biologics [EB/OL]. [2002-05-01]. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatorylrfformation/Guidances/ucm070551. pdf.
4Odenhoh - Tornqvist I, Lowdin E, Cars O. Postantibiotic sub - MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin [ J ]. Antimicrob Agents Chemother, 1992 ; 36:1852 - 1858.
5Jacobs MR. Pharmacodynamic breakpoints:new concepts for old problems[ C]. ISAAR, 2001:178 - 186.